OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
7,020.00
-120.00 (-1.68%)
Last updated: Oct 10, 2025, 12:33 PM KST
OPTUS Pharmaceutical Revenue
OPTUS Pharmaceutical had revenue of 21.79B KRW in the quarter ending June 30, 2025, with 4.10% growth. This brings the company's revenue in the last twelve months to 82.81B, up 6.46% year-over-year. In the year 2024, OPTUS Pharmaceutical had annual revenue of 81.90B with 13.09% growth.
Revenue (ttm)
82.81B
Revenue Growth
+6.46%
P/S Ratio
1.33
Revenue / Employee
520.83M
Employees
159
Market Cap
110.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81.90B | 9.48B | 13.09% |
Dec 31, 2023 | 72.43B | 13.77B | 23.47% |
Dec 31, 2022 | 58.66B | 1.34B | 2.34% |
Dec 31, 2021 | 57.32B | -3.51B | -5.77% |
Dec 31, 2020 | 60.83B | 385.58M | 0.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Doosan Enerbility | 16.30T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |